1. Preventing SCD With a WCD: Reviewing the Results of the VEST Trial

3. Overview

4. 2017 ACC/AHA/HRS Guideline on the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

5. Risk Stratification

6. Early ICD Not Advisable

7. Wearable Cardioverter-Defibrillator

8. Primary Prevention of SCD in Patients With IHD

9. Waiting Period for ICD

10. Secondary and Primary Prevention of SCD in Patients With Nonischemic Cardiomyopathy

11. Current Indications for WCD

12. Wearable Cardioverter Defibrillator

13. Observational Studies of WCD Patient Types Studied

14. Aggregate US Nationwide Data on WCD

15. Aggregate Germany Nationwide Data on WCD

16. Rationale for VEST Trial

17. VEST Eligibility Criteria

18. VEST Design

19. VEST Design (cont)

20. VEST Screening and Enrollment

21. VEST Results: Demographics

22. VEST Results: Characteristics of Index MI

23. VEST Results: Medical Treatment

24. VEST Results: Crossover Treatment

25. VEST Results: WCD Wear Time

26. VEST Results: Primary Outcome

27. VEST Results: Non-Sudden Death

28. VEST Results: Death From Any Cause

29. VEST: Sudden Death vs Total Mortality

30. Applying VEST Results to Clinical Care

31. Applying VEST Results to Clinical Care (cont)

32. Shared Decision-Making

33. Abbreviations

34. Abbreviations (cont)